Genmab
David Soong is a seasoned professional in translational data science with extensive experience in oncology and biomarker research. Since July 2019, David has served as the Director of Translational Data Science at Genmab, leading data science efforts for Epcoritamab and spearheading the development of a global analytical platform for clinical research. Prior to Genmab, David held positions at Johnson & Johnson as Associate Director and Principal Scientist, focusing on cancer genomics and biomarker planning for DARZALEX. David also worked as a Computational Biology Investigator at GlaxoSmithKline, contributing to drug discovery in oncology, and as a post-doctoral research scientist at Weill Cornell Medical College and Columbia University, where David conducted significant research in chromatin architecture and structural genomics. David earned a PhD in Biomedical Informatics from Columbia University Vagelos College of Physicians and Surgeons.
This person is not in any offices
Genmab
42 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.